How to identify severe flu symptoms in children
Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Watch CBS News
Flu cases are surging nationwide and 27 children are among those who have died this flu season. One hospital shares ways to be on the lookout for respiratory issues. Janet Shamlian reports.
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Smoking is notorious for causing damage to the lungs — but a recent study confirmed that it’s also harmful to the brain. Researchers from the Washington University School of Medicine (WashUMed) in St. Louis, Missouri, analyzed the brain scans, smoking history and genetic risk of 32,094 participants of European descent from the UK Biobank database….
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering…
Jim Cramer ran through all 33 stocks in his Charitable Trust portfolio during the December edition of the CNBC Investing Club’s Monthly Meeting.
Hospitals dealing with influx of kids with respiratory illnesses – CBS News Watch CBS News The new year is bringing a surge in cases of RSV and the flu among kids. Hospitals across the country are dealing with a surge in cases and, in some cases, a lack of beds. Janet Shamlian reports. Be the…
For many struggling with obesity, new medications have been “a gift,” as Oprah Winfrey recently described it in declaring she was “done with the shaming.” Investors in drug manufacturers Novo Nordisk and Eli Lilly might use the same term for the returns they’ve realized over the past year. U.S.-listed shares of Novo Nordisk, the maker…
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies —…